This inventor holds 2 USPTO granted patents. Top assignee: Chemo-Sero-Therapeutic Research Institute. Active years: 1992-1996.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Location History:
- Kumamoto, JP (1992)
- Kikuchi-gun, JP (1996)
Company Filing History:
Years Active: 1992-1996
Title: Michitaka Yamamoto: Innovator in Marek's Disease Research
Introduction
Michitaka Yamamoto is a prominent inventor based in Kumamoto, Japan. He has made significant contributions to the field of veterinary medicine, particularly in the development of vaccines for birds. With a total of 2 patents, his work focuses on recombinant Marek's disease viruses.
Latest Patents
Yamamoto's latest patents include innovative methods for preparing recombinant Marek's disease viruses. One patent describes a recombinant Marek's disease virus produced by mutating a Marek's disease virus with a plasmid. This plasmid contains a gene fragment derived from the Us region of the Marek's disease virus genome and an exogenous gene expression cassette. The second patent outlines a process for preparing a recombinant Marek's disease virus that incorporates a promoter and a structural gene coding for an exogenous protein into a gene fragment derived from the Marek's disease virus.
Career Highlights
Yamamoto is affiliated with the Juridical Foundation the Chemo-sero-therapeutic Research Institute. His work has been instrumental in advancing the understanding and treatment of Marek's disease in poultry, which is crucial for the agricultural sector.
Collaborations
Some of his notable coworkers include Masashi Sakaguchi and Hiroaki Maeda. Their collaborative efforts have further enhanced the research and development of effective vaccines.
Conclusion
Michitaka Yamamoto's contributions to the field of veterinary medicine through his innovative patents are noteworthy. His work continues to impact the health and well-being of birds, showcasing the importance of research in combating diseases.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile